REPORT ID 1267

China Substance Abuse Treatment Market Research Report 2017

Publish Date
05-Dec-17
Pages
99
Format
Electronic (PDF)

The global Substance Abuse Treatment market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Substance Abuse Treatment development status and future trend in China, focuses on top players in China, also splits Substance Abuse Treatment by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Alkermes
    Allergan
    GSK
    Pfizer
    Accord Healthcare
    Amphastar Pharmaceuticals
    Apotex
    BioCorRx
    Cipla
    Glenmark

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Alcohol Abuse Treatment
    Nicotine Abuse Treatment
    Drug Abuse Treatment

On the basis of the end users/application, this report covers
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Substance Abuse Treatment Market Research Report 2017
1 Substance Abuse Treatment Overview
    1.1 Product Overview and Scope of Substance Abuse Treatment
    1.2 Classification of Substance Abuse Treatment by Product Category
        1.2.1 China Substance Abuse Treatment Sales (K Units) Comparison by Type (2012-2022)
        1.2.2 China Substance Abuse Treatment Sales (K Units) Market Share by Type in 2016
        1.2.3 Alcohol Abuse Treatment
        1.2.4 Nicotine Abuse Treatment
        1.2.5 Drug Abuse Treatment
    1.3 China Substance Abuse Treatment Market by Application/End Users
        1.3.1 China Substance Abuse Treatment Sales (K Units) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 China Substance Abuse Treatment Market by Region
        1.4.1 China Substance Abuse Treatment Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Substance Abuse Treatment Status and Prospect (2012-2022)
        1.4.3 East China Substance Abuse Treatment Status and Prospect (2012-2022)
        1.4.4 Southwest China Substance Abuse Treatment Status and Prospect (2012-2022)
        1.4.5 Northeast China Substance Abuse Treatment Status and Prospect (2012-2022)
        1.4.6 North China Substance Abuse Treatment Status and Prospect (2012-2022)
        1.4.7 Central China Substance Abuse Treatment Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Substance Abuse Treatment (2012-2022)
        1.5.1 China Substance Abuse Treatment Sales (K Units) and Growth Rate (%)(2012-2022)
        1.5.2 China Substance Abuse Treatment Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Substance Abuse Treatment Market Competition by Players/Manufacturers
    2.1 China Substance Abuse Treatment Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Substance Abuse Treatment Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Substance Abuse Treatment Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.4 China Substance Abuse Treatment Market Competitive Situation and Trends
        2.4.1 China Substance Abuse Treatment Market Concentration Rate
        2.4.2 China Substance Abuse Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Substance Abuse Treatment Manufacturing Base Distribution, Sales Area, Product Types

3 China Substance Abuse Treatment Sales and Revenue by Region (2012-2017)
    3.1 China Substance Abuse Treatment Sales (K Units) and Market Share by Region (2012-2017)
    3.2 China Substance Abuse Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Substance Abuse Treatment Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Substance Abuse Treatment Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Substance Abuse Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Substance Abuse Treatment Price (USD/Unit) by Type (2012-2017)
    4.4 China Substance Abuse Treatment Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Substance Abuse Treatment Sales (K Units) and Market Share by Application (2012-2017)
    5.2 China Substance Abuse Treatment Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Substance Abuse Treatment Players/Suppliers Profiles and Sales Data
    6.1 Alkermes
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Substance Abuse Treatment Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Alkermes Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Allergan
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Substance Abuse Treatment Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Allergan Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Substance Abuse Treatment Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Substance Abuse Treatment Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Accord Healthcare
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Substance Abuse Treatment Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Accord Healthcare Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Amphastar Pharmaceuticals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Substance Abuse Treatment Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Apotex
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Substance Abuse Treatment Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Apotex Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 BioCorRx
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Substance Abuse Treatment Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 BioCorRx Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Cipla
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Substance Abuse Treatment Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Cipla Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Glenmark
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Substance Abuse Treatment Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Glenmark Substance Abuse Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview

7 Substance Abuse Treatment Manufacturing Cost Analysis
    7.1 Substance Abuse Treatment Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Substance Abuse Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Substance Abuse Treatment Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Substance Abuse Treatment Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Substance Abuse Treatment Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Substance Abuse Treatment Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Substance Abuse Treatment Sales (K Units) Forecast by Type (2017-2022)
    11.3 China Substance Abuse Treatment Sales (K Units) Forecast by Application (2017-2022)
    11.4 China Substance Abuse Treatment Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List